“Growing Adoption of Wearable Drug Delivery Devices in Asia-Pacific”
- The Asia-Pacific region is witnessing a surge in wearable drug delivery devices due to their ability to provide precise, continuous, and user-friendly medication for long-term conditions such as diabetes and cancer
- These devices enable at-home treatment, minimizing the need for hospital visits
- For instance, wearable insulin injectors allow diabetes patients to self-administer doses conveniently
- Japan and South Korea are integrating wearable drug devices into mobile health platforms, with companies such as Omron Healthcare offering connected wearable solutions to track adherence
- Government-backed digital health initiatives across Asia, including remote monitoring programs in South Korea and Japan, are encouraging widespread adoption of smart wearable injectors
- Startups in China and India, such as Ypsomed and Healthium Medtech, are creating affordable wearable delivery technologies, catering to tech-savvy urban populations and boosting local innovation
